Dr Funkenstein by Unknown Or Legendary
Indica-dominant genetics
Dr Funkenstein is a storied indica-dominant strain developed by Unknown or Legendary. It is recognized for its intricate aroma and flavor profile, combined with potent, relaxing effects, making it a favored choice for evening use.
Appearance
Dr Funkenstein buds are dense and compact, characteristic of its indica heritage. They are often covered in abundant trichomes, giving them a frosty appearance. The coloration is typically deep green with purple hues and occasional burnt orange pistils.
Aroma & Flavor
The aroma of Dr Funkenstein is complex, with dominant notes of earthiness, spice, and a hint of citrus. Users often detect a pungent, medicinal quality reminiscent of aged herbal remedies. The flavor mirrors the aroma, presenting a bold, earthy taste with spicy undertones and a subtle sweetness.
Effects
This strain delivers a potent indica-dominant experience, characterized by a rapid onset of deep body relaxation. It is also known to provide a mild cerebral uplift, making it suitable for evening or nighttime use. Many users report significant stress relief and muscle relaxation.
Terpenes & Cannabinoids
Dr Funkenstein features a terpene profile dominated by Myrcene, Limonene, and Caryophyllene, contributing to its earthy, citrus, and spicy notes. Cannabinoid analysis typically shows THC levels between 18% and 22%, with minimal CBD content (under 1%).
Growing
While specific cultivation details are not extensively documented, its indica genetics suggest a resilient plant. The dense bud structure and high resin production are appreciated by cultivators. Information regarding difficulty, flowering time, yield, and optimal environment is not specified in the source notes.
Origins & Lineage
Dr Funkenstein is attributed to the breeder Unknown or Legendary. The strain is believed to be the result of meticulous breeding and selection of potent indica genetics, with over 80% of its lineage tracing back to classical indica strains. It first gained recognition in niche markets around the mid-2000s.